Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant disease control in HSPC patients
Guiding metastasis-directed therapy with different PET/CT radiotracers affects distant disease control in HSPC patients
Bladder cancer updates from the second half of 2024
30 minute infusion of isatuximab shows potential in newly diagnosed multiple myeloma
EMUC 2024: Optimising strategies in mHSPC and mCRPC
SIOG 2024: Updates in haematology
One-year mortality in older adults with breast cancer: prediction using different geriatric tools
Isa-VRd shows greater efficacy compared to VRd in transplant-ineligible NDMM patients
Optimising benefit-risk and minimising impact on quality of life with BCMA-targeting agents in an outpatient setting
Understanding the remaining unmet needs in a post ASCT NDMM setting
Approaches to risk stratification in high risk myeloma
Use of bispecifics and CAR T cells in South America
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM